@article{goossens_cost-utility_2008,
	title = {The cost-utility of rotavirus vaccination with {Rotarix}™ ({RIX4414}) in the {Netherlands}},
	volume = {26},
	issn = {0264-410X},
	url = {http://www.sciencedirect.com/science/article/pii/S0264410X07013564},
	doi = {10.1016/j.vaccine.2007.11.070},
	abstract = {Summary
The objective of this study was to estimate the cost-utility of mass vaccination of 0–4-year-old children with Rotarix™ in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective. Utility loss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the questions. As the costs of a vaccination course ranged from €90 to €100 per child, the cost-utility ratio varied from €21,900 to €35,076 per QALY gained. Based on the current study, it is clear that mass vaccination with Rotarix™ against rotavirus gastroenteritis can be attractive, from an economic and a health care perspective.},
	number = {8},
	urldate = {2015-03-03},
	journal = {Vaccine},
	author = {Goossens, Lucas M. A. and Standaert, Baudouin and Hartwig, Nico and Hövels, Anke M. and Al, Maiwenn J.},
	month = feb,
	year = {2008},
	pages = {1118--1127},
}

{"_id":"XhmAuWoWc9Aphssqg","bibbaseid":"goossens-standaert-hartwig-hvels-al-thecostutilityofrotavirusvaccinationwithrotarixrix4414inthenetherlands-2008","author_short":["Goossens, L. M. A.","Standaert, B.","Hartwig, N.","Hövels, A. M.","Al, M. J."],"bibdata":{"bibtype":"article","type":"article","title":"The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands","volume":"26","issn":"0264-410X","url":"http://www.sciencedirect.com/science/article/pii/S0264410X07013564","doi":"10.1016/j.vaccine.2007.11.070","abstract":"Summary The objective of this study was to estimate the cost-utility of mass vaccination of 0–4-year-old children with Rotarix™ in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective. Utility loss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the questions. As the costs of a vaccination course ranged from €90 to €100 per child, the cost-utility ratio varied from €21,900 to €35,076 per QALY gained. Based on the current study, it is clear that mass vaccination with Rotarix™ against rotavirus gastroenteritis can be attractive, from an economic and a health care perspective.","number":"8","urldate":"2015-03-03","journal":"Vaccine","author":[{"propositions":[],"lastnames":["Goossens"],"firstnames":["Lucas","M.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Standaert"],"firstnames":["Baudouin"],"suffixes":[]},{"propositions":[],"lastnames":["Hartwig"],"firstnames":["Nico"],"suffixes":[]},{"propositions":[],"lastnames":["Hövels"],"firstnames":["Anke","M."],"suffixes":[]},{"propositions":[],"lastnames":["Al"],"firstnames":["Maiwenn","J."],"suffixes":[]}],"month":"February","year":"2008","pages":"1118–1127","bibtex":"@article{goossens_cost-utility_2008,\n\ttitle = {The cost-utility of rotavirus vaccination with {Rotarix}™ ({RIX4414}) in the {Netherlands}},\n\tvolume = {26},\n\tissn = {0264-410X},\n\turl = {http://www.sciencedirect.com/science/article/pii/S0264410X07013564},\n\tdoi = {10.1016/j.vaccine.2007.11.070},\n\tabstract = {Summary\nThe objective of this study was to estimate the cost-utility of mass vaccination of 0–4-year-old children with Rotarix™ in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective. Utility loss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the questions. As the costs of a vaccination course ranged from €90 to €100 per child, the cost-utility ratio varied from €21,900 to €35,076 per QALY gained. Based on the current study, it is clear that mass vaccination with Rotarix™ against rotavirus gastroenteritis can be attractive, from an economic and a health care perspective.},\n\tnumber = {8},\n\turldate = {2015-03-03},\n\tjournal = {Vaccine},\n\tauthor = {Goossens, Lucas M. A. and Standaert, Baudouin and Hartwig, Nico and Hövels, Anke M. and Al, Maiwenn J.},\n\tmonth = feb,\n\tyear = {2008},\n\tpages = {1118--1127},\n}\n\n","author_short":["Goossens, L. M. A.","Standaert, B.","Hartwig, N.","Hövels, A. M.","Al, M. J."],"key":"goossens_cost-utility_2008","id":"goossens_cost-utility_2008","bibbaseid":"goossens-standaert-hartwig-hvels-al-thecostutilityofrotavirusvaccinationwithrotarixrix4414inthenetherlands-2008","role":"author","urls":{"Paper":"http://www.sciencedirect.com/science/article/pii/S0264410X07013564"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/robin.marlow","dataSources":["ix72eqAAMGCuupBaz"],"keywords":[],"search_terms":["cost","utility","rotavirus","vaccination","rotarix","rix4414","netherlands","goossens","standaert","hartwig","hövels","al"],"title":"The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands","year":2008}